Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis.
OBJECTIVE: Antineutrophil cytoplasmic antibody-associated vasculitis (AAV) can present with a broad spectrum of signs and symptoms. The relative effects of different manifestations on health-related quality of life (HRQOL) are unknown. METHODS: We conducted an individual patient data meta-analysis o...
Hlavní autoři: | Walsh, M, Mukhtyar, C, Mahr, A, Herlyn, K, Luqmani, R, Merkel, P, Jayne, DR |
---|---|
Médium: | Journal article |
Jazyk: | English |
Vydáno: |
2011
|
Podobné jednotky
-
Remission in antineutrophil cytoplasmic antibody-associated systemic vasculitis.
Autor: Mukhtyar, C, a další
Vydáno: (2006) -
Cardiovascular outcomes in antineutrophil cytoplasm antibody associated vasculitis (AAV)
Autor: Mukhtyar, C, a další
Vydáno: (2008) -
Should rituximab be used to treat antineutrophil cytoplasmic antibody associated vasculitis?
Autor: Flossmann, O, a další
Vydáno: (2006) -
Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force.
Autor: Mukhtyar, C, a další
Vydáno: (2008) -
OMERACT endorsement of patient-reported outcome instruments in antineutrophil cytoplasmic antibody–associated vasculitis
Autor: Robson, J, a další
Vydáno: (2017)